Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl-Josef Langen

Showing results (11-20 of 240) with videos related to

Pageof 24
Sort By:
Case Reports in Oncology|December 29, 2012
Discrepant MR and [(18)F]Fluoroethyl-L-Tyrosine PET Imaging Findings in a Patient with Bevacizumab FailureNorbert Galldiks, Christian P Filss, Roland Goldbrunner, et al.
Clinical Nuclear Medicine|July 27, 2019
Dynamic FET PET Imaging of a "Butterfly" IDH-Wildtype Anaplastic AstrocytomaNorbert Galldiks, Anna Brunn, Gereon R Fink, et al.
Seminars in Nuclear Medicine|October 3, 2012
Brain tumorsKarl Herholz, Karl-Josef Langen, Christiaan Schiepers, et al.
Advances in Experimental Medicine and Biology|July 11, 2023
Imaging Characteristics of MeningiomasNorbert Galldiks, Elke Hattingen, Karl-Josef Langen, et al.
Nature Reviews. Neurology|April 8, 2017
Advances in neuro-oncology imagingKarl-Josef Langen, Norbert Galldiks, Elke Hattingen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2023
Amino Acid PET in NeurooncologyNorbert Galldiks, Philipp Lohmann, Gereon R Fink, et al.
Neuroimage. Clinical|January 25, 2017
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapyNorbert Galldiks, Ian Law, Whitney B Pope, et al.
Expert Review of Neurotherapeutics|December 13, 2019
Advantages and limitations of amino acid PET for tracking therapy response in glioma patientsKarl-Josef Langen, Alexander Heinzel, Philipp Lohmann, et al.
Journal of Craniovertebral Junction & Spine|July 12, 2014
(68)Ga-DOTATATE-positron emission tomography imaging in spinal meningiomaPhilipp Jörg Slotty, Florian Friedrich Behrendt, Karl-Josef Langen, et al.
Nuklearmedizin. Nuclear Medicine|April 15, 2025
The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023Ralph Buchert, Alexander Drzezga, Mathias Schreckenberger, et al.
Pageof 24

Showing results (11-20 of 240) with videos related to

Sort By:
Pageof 24
Case Reports in Oncology|December 29, 2012
Discrepant MR and [(18)F]Fluoroethyl-L-Tyrosine PET Imaging Findings in a Patient with Bevacizumab FailureNorbert Galldiks, Christian P Filss, Roland Goldbrunner, et al.
Clinical Nuclear Medicine|July 27, 2019
Dynamic FET PET Imaging of a "Butterfly" IDH-Wildtype Anaplastic AstrocytomaNorbert Galldiks, Anna Brunn, Gereon R Fink, et al.
Seminars in Nuclear Medicine|October 3, 2012
Brain tumorsKarl Herholz, Karl-Josef Langen, Christiaan Schiepers, et al.
Advances in Experimental Medicine and Biology|July 11, 2023
Imaging Characteristics of MeningiomasNorbert Galldiks, Elke Hattingen, Karl-Josef Langen, et al.
Nature Reviews. Neurology|April 8, 2017
Advances in neuro-oncology imagingKarl-Josef Langen, Norbert Galldiks, Elke Hattingen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2023
Amino Acid PET in NeurooncologyNorbert Galldiks, Philipp Lohmann, Gereon R Fink, et al.
Neuroimage. Clinical|January 25, 2017
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapyNorbert Galldiks, Ian Law, Whitney B Pope, et al.
Expert Review of Neurotherapeutics|December 13, 2019
Advantages and limitations of amino acid PET for tracking therapy response in glioma patientsKarl-Josef Langen, Alexander Heinzel, Philipp Lohmann, et al.
Journal of Craniovertebral Junction & Spine|July 12, 2014
(68)Ga-DOTATATE-positron emission tomography imaging in spinal meningiomaPhilipp Jörg Slotty, Florian Friedrich Behrendt, Karl-Josef Langen, et al.
Nuklearmedizin. Nuclear Medicine|April 15, 2025
The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023Ralph Buchert, Alexander Drzezga, Mathias Schreckenberger, et al.
Pageof 24